XIAOMI-W
01810
BABA-W
09988
ALI HEALTH
00241
KUAISHOU-W
01024
BIDU-SW
09888
(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | ---- | 76.95%31.34B | ---- | ---- | ---- | 346.48%17.71B | ---- | ---- |
Profit adjustment | ||||||||||
Investment loss (gain) | ---- | ---- | ---- | -312.58%-1.64B | ---- | ---- | ---- | 2,531.74%769.18M | ---- | ---- |
Impairment and provisions: | ---- | ---- | ---- | 58.58%3.77B | ---- | ---- | ---- | 90.76%2.38B | ---- | ---- |
-Other impairments and provisions | ---- | ---- | ---- | 59.63%1.58B | ---- | ---- | ---- | 154.98%989.52M | ---- | ---- |
Revaluation surplus: | ---- | ---- | ---- | -104.40%-257.74M | ---- | ---- | ---- | -166.28%-126.1M | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | 20.27%1.05B | ---- | ---- | ---- | 676.69%876.12M | ---- | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | 20.27%1.05B | ---- | ---- | ---- | 676.69%876.12M | ---- | ---- |
Depreciation and amortization: | ---- | ---- | ---- | 113.81%43.55B | ---- | ---- | ---- | 44.38%20.37B | ---- | ---- |
-Amortization of intangible assets | ---- | ---- | ---- | -18.14%4.17B | ---- | ---- | ---- | 74.14%5.1B | ---- | ---- |
-Other depreciation and amortization | ---- | ---- | ---- | 231.12%270.15M | ---- | ---- | ---- | 199.04%81.59M | ---- | ---- |
Financial expense | ---- | ---- | ---- | -14.06%529.61M | ---- | ---- | ---- | -67.69%616.27M | ---- | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | ---- | 79.21%-7.6B | ---- | ---- | ---- | -183.60%-36.56B | ---- | ---- |
Accounts receivable (increase)decrease | ---- | ---- | ---- | 27.96%-12.64B | ---- | ---- | ---- | -1,369.05%-17.55B | ---- | ---- |
Accounts payable increase (decrease) | ---- | ---- | ---- | -26.09%112.74B | ---- | ---- | ---- | 174.36%152.53B | ---- | ---- |
Special items of business | ---- | ---- | ---- | -543.79%-1.12B | ---- | ---- | ---- | -246.79%-174.62M | ---- | ---- |
Adjustment items of business operations | -42.50%56.27B | -82.70%14.18B | -29.29%10.23B | 21.16%170.85B | 7.50%97.86B | 89.81%81.97B | 21.22%14.47B | 115.79%141.01B | 185.62%91.04B | 346.27%43.19B |
Net cash from operations | -42.50%56.27B | -82.70%14.18B | -29.29%10.23B | 20.51%169.73B | 7.50%97.86B | 89.81%81.97B | 21.22%14.47B | 115.13%140.84B | 185.62%91.04B | 346.27%43.19B |
Cash flow from investment activities | ||||||||||
Dividend received - investment | 340.35%838.34M | 127.56%351.31M | -17.25%114.23M | 48.77%192.41M | 152.67%190.38M | 242.59%154.38M | 325.77%138.04M | -36.57%129.33M | -42.59%75.35M | -62.89%45.06M |
Sale of fixed assets | 38.24%529.57M | 28.59%310.81M | -77.77%36.99M | 75.51%470.79M | 47.91%383.07M | 32.27%241.72M | 122.95%166.39M | -67.54%268.24M | -60.15%258.98M | 52.50%182.75M |
Purchase of fixed assets | 31.15%-69.52B | 28.38%-47.23B | 19.36%-26.09B | -25.28%-122.09B | -57.08%-100.97B | -82.51%-65.94B | -140.50%-32.36B | -160.97%-97.46B | -210.24%-64.28B | -247.15%-36.13B |
Sale of subsidiaries | -89.22%18.88M | -88.83%16.4M | ---- | 105.07%196.46M | --175.13M | --146.81M | ---- | -56.91%95.8M | ---- | ---- |
Acquisition of subsidiaries | ---- | ---- | ---- | ---14.08B | ---- | ---- | ---- | ---- | ---- | ---- |
Recovery of cash from investments | --16.5M | --16.5M | ---- | ---- | ---- | ---- | ---- | --13.78M | --13.78M | --13.78M |
Cash on investment | -103.30%-2.98B | -82.57%-1.75B | -318.20%-1.61B | 80.28%-2.08B | 80.74%-1.47B | 61.02%-960.27M | 77.43%-384.14M | -199.79%-10.57B | -696.96%-7.62B | -258.93%-2.46B |
Other items in the investment business | -313.63%-15.55B | -197.09%-7.59B | -97.13%280M | 189.75%11.73B | 160.12%7.28B | 275.41%7.82B | 297.10%9.74B | -125.94%-13.07B | -767.03%-12.11B | -115.59%-4.46B |
Net cash from investment operations | 8.21%-86.65B | 4.55%-55.87B | -20.14%-27.27B | -4.20%-125.66B | -12.85%-94.4B | -36.74%-58.54B | -80.19%-22.7B | -165.61%-120.6B | -275.32%-83.66B | -231.36%-42.81B |
Net cash before financing | -978.77%-30.38B | -277.92%-41.7B | -107.03%-17.04B | 117.68%44.06B | -53.16%3.46B | 6,106.25%23.43B | -1,141.67%-8.23B | 0.89%20.24B | -23.01%7.38B | 111.65%377.6M |
Cash flow from financing activities | ||||||||||
New borrowing | 19.72%26.83B | -22.52%13.26B | -3.86%12.7B | 63.93%45.3B | 14.14%22.41B | -11.94%17.11B | 75.23%13.21B | -15.93%27.64B | -29.71%19.64B | 0.10%19.44B |
Refund | -76.86%-29.54B | -103.02%-23.69B | -2,546.65%-17.14B | 38.18%-27.23B | 44.07%-16.7B | 50.18%-11.67B | 95.71%-647.47M | 11.69%-44.05B | 19.61%-29.86B | 24.64%-23.42B |
Issuance of bonds | --2.96B | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Dividends paid - financing | -118.53%-9.99B | 60.89%-333.76M | 3.86%-232.18M | -151.19%-4.1B | -190.57%-4.57B | -15.81%-853.41M | 35.73%-241.5M | 37.66%-1.63B | 33.68%-1.57B | 41.27%-736.93M |
Absorb investment income | --98M | --98M | ---- | -80.69%98M | ---- | ---- | ---- | -98.64%507.63M | -98.15%472.63M | -98.90%276.63M |
Other items of the financing business | -162.85%-2.32B | -212.56%-1.7B | -88.59%-518.59M | 35.79%-1.25B | 81.10%-883.69M | 88.10%-542.47M | -169.47%-274.99M | -20.00%-1.95B | -0.77%-4.68B | -202.27%-4.56B |
Net cash from financing operations | -4,768.45%-11.96B | -405.13%-12.36B | -143.02%-5.18B | 165.77%12.82B | 101.60%256.22M | 144.99%4.05B | 266.13%12.05B | -221.33%-19.49B | -271.18%-16B | -184.61%-9B |
Effect of rate | -198.08%-363.4M | -141.19%-230.98M | 1.10%-107.84M | -26.06%450.78M | -12.82%370.51M | 295.62%560.79M | -524.63%-109.04M | 1,490.40%609.62M | 5,073.10%425M | 771.72%141.75M |
Net Cash | -1,240.28%-42.34B | -296.67%-54.05B | -682.05%-22.23B | 7,453.82%56.88B | 143.08%3.71B | 418.68%27.49B | 148.23%3.82B | -97.92%752.98M | -145.53%-8.62B | -216.59%-8.62B |
Begining period cash | 112.01%108.51B | 112.01%108.51B | 112.01%108.51B | 2.74%51.18B | 2.74%51.18B | 2.74%51.18B | 2.74%51.18B | 262.63%49.82B | 262.63%49.82B | 262.63%49.82B |
Cash at the end | 19.08%65.81B | -31.56%54.23B | 57.00%86.18B | 112.01%108.51B | 32.77%55.27B | 91.67%79.23B | 30.92%54.89B | 2.74%51.18B | 27.45%41.63B | 95.43%41.34B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- | -- | Ernst & Young Huaming Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.